| |
| |
|
| Insider
Information: |
Homcy Charles J |
| Relationship: |
Director |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
1,546,413 |
|
|
Indirect Shares
|
188,122 |
|
|
| Direct
Value |
$41,253,491 |
|
|
|
Indirect Value
|
$3,452,400 |
|
|
| Total
Shares |
1,734,535 |
|
|
| Total
Value |
$44,705,891 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Millennium Pharmaceuticals Inc |
MLNM |
Director |
2008-05-09 |
0 |
2004-02-17 |
1,119 |
Premium* |
|
|
Geron Corporation |
GERN |
Director |
2011-05-11 |
62,751 |
2007-01-03 |
0 |
Premium* |
|
|
Portola Pharmaceuticals Inc |
PTLA |
Director |
2019-01-02 |
112,471 |
2019-01-02 |
185,403 |
Premium* |
|
|
Global Blood Therapeutics, Inc. |
GBT |
Director |
2017-10-27 |
67,728 |
2017-10-27 |
1,600 |
Premium* |
|
|
Bridgebio Pharma, Inc. |
BBIO |
|
2024-02-16 |
1,230,085 |
2019-07-01 |
0 |
Premium* |
|
|
Pliant Therapeutics, Inc. |
PLRX |
Director |
2020-06-02 |
73,378 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
108 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PTLA |
Portola Pharmaceuticals I... |
Director |
– • – |
2016-06-17 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
3,000 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
– • – |
2017-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
3,000 |
0 |
- |
|
| PTLA |
Portola Pharmaceuticals I... |
Director |
– • – |
2018-06-08 |
4 |
A |
$0.00 |
$0 |
D/D |
3,000 |
115,471 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
Director |
– • – |
2022-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,759 |
1,208,523 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
Director |
– • – |
2023-05-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,759 |
1,222,127 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
Director |
– • – |
2022-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,760 |
1,210,742 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
Director |
– • – |
2022-11-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,760 |
1,215,552 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
Director |
– • – |
2023-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,760 |
1,219,902 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
Director |
– • – |
2023-08-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,760 |
1,225,838 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
Director |
– • – |
2023-11-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,760 |
1,228,297 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
|
– • – |
2024-02-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,760 |
1,231,594 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2010-05-19 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
70,251 |
0 |
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2011-05-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,000 |
120,251 |
0 |
- |
|
| MLNM |
Millennium Pharmaceutical... |
Director |
– • – |
2003-09-04 |
4 |
S |
$14.92 |
$76,424 |
D/D |
(5,121) |
106,487 |
|
- |
|
| GERN |
Geron Corporation |
Director |
– • – |
2007-05-23 |
4 |
A |
$0.00 |
$0 |
D/D |
7,146 |
27,146 |
0 |
- |
|
| MLNM |
Millennium Pharmaceutical... |
Director |
– • – |
2007-01-23 |
4 |
OE |
$6.34 |
$45,807 |
D/D |
7,225 |
119,063 |
0 |
- |
|
| MLNM |
Millennium Pharmaceutical... |
Director |
– • – |
2007-09-17 |
4 |
AS |
$9.76 |
$97,635 |
D/D |
(10,000) |
83,683 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
Chairman of Pharmaceuticals |
• • – |
2020-01-14 |
4 |
OE |
$17.00 |
$170,000 |
D/D |
10,000 |
1,372,291 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
Chairman of Pharmaceuticals |
• • – |
2020-01-14 |
4 |
AS |
$35.00 |
$350,000 |
D/D |
(10,000) |
1,362,291 |
0 |
% |
|
| BBIO |
Bridgebio Pharma, Inc. |
Chairman of Pharmaceuticals |
• • – |
2020-09-30 |
4 |
OE |
$17.00 |
$170,000 |
D/D |
10,000 |
1,213,767 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
Chairman of Pharmaceuticals |
• • – |
2020-09-30 |
4 |
AS |
$38.00 |
$380,000 |
D/D |
(10,000) |
1,203,767 |
0 |
% |
|
| GERN |
Geron Corporation |
Director |
– • – |
2008-05-28 |
4 |
A |
$0.00 |
$0 |
D/D |
10,038 |
37,184 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
Chairman of Pharmaceuticals |
• • – |
2020-10-16 |
4 |
OE |
$17.00 |
$174,352 |
D/D |
10,256 |
1,214,023 |
0 |
- |
|
| BBIO |
Bridgebio Pharma, Inc. |
Chairman of Pharmaceuticals |
• • – |
2020-10-16 |
4 |
AS |
$41.00 |
$420,496 |
D/D |
(10,256) |
1,203,767 |
0 |
% |
|
| GBT |
Global Blood Therapeutics... |
Director |
– • – |
2016-12-16 |
5 |
A |
$0.00 |
$0 |
D/D |
10,432 |
237,728 |
0 |
- |
|
108 Records found
|
|
Page 2 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
